anthrax

Latest stories

  • HHS Orders Elusys Anthrax Treatment for Strategic National Stockpile - top government contractors - best government contracting event
    in News, Products & Service

    HHS Orders Elusys Anthrax Treatment for Strategic National Stockpile

    The Department of Health and Human Services has awarded Elusys Therapeutics a $25.2 million contract to supply an anthrax treatment for the country’s national repository of medical countermeasures for public health emergency use. HHS said Monday its Biomedical Advanced Research and Development Authority provided funds for the company to produce the Anthim monoclonal antibody injection as part of Project BioShield. Elusys will […] More

  • Elusys Delivers Second Anthrax Treatment Batch to US Strategic National Stockpile Program - top government contractors - best government contracting event
    in Healthcare IT, News

    Elusys Delivers Second Anthrax Treatment Batch to US Strategic National Stockpile Program

    Elusys Therapeutics has delivered a second batch of monoclonal antibody injections designed for inhalation anthrax treatment to the Strategic National Stockpile after the company received $16.35 million in funds as part of a potential $45 million procurement contract from the U.S. government. The company said Tuesday its ANTHIM injection contains a neutralizing toxin that works to help prevent the spread of anthrax and potential tissue damage in the human body. […] More

  • DARPA to Host Workshop on Synthetic Polymer-Based Medicine R&D Program - top government contractors - best government contracting event
    in Industry News, News

    DARPA to Host Workshop on Synthetic Polymer-Based Medicine R&D Program

    The Defense Advanced Research Projects Agency will conduct a workshop in Southbridge, Massachusetts, on June 29 to discuss a program that seeks to develop medicines designed to retain potency for long periods of time amid exposure to extreme conditions on the battlefield. DARPA said Tuesday researchers under the Fold F(x) program aim to design biotherapeutics and […] More

  • NIH Allergy Institute Taps Emergent BioSolutions for Anthrax Vaccine Dry Formulation; Adam Havey Comments - top government contractors - best government contracting event
    in Healthcare IT, News

    NIH Allergy Institute Taps Emergent BioSolutions for Anthrax Vaccine Dry Formulation; Adam Havey Comments

    Emergent BioSolutions has landed a five-year, $29 million contract with the National Institute of Allergy and Infectious Diseases to make a dry formulation of the NuThrax anthrax vaccine candidate in an effort to facilitate shipping and storage at normal temperatures. The company said Monday the contract covers manufacturing, non-clinical processes and application to the U.S. Food and Drug Administration for Investigational New Drug status. “We […] More

    by